Images
Contact
Iproteos, a spin-off from IRB Barcelona and the University of Barcelona, has been awarded the '2nd RedEmprendia University to Business Spin-off Prize 2012’, which was presented on Wednesday 28 November during the international ‘RedEmprendia Spin2012’ conference held in Madrid.
The “1st University to Business Spin-off Prize 2012”, awarded 25,000 euros and sponsored by PWC España, went to Xeiba Open Innovation Center, at the “Tecnológico de Monterrey (Mexico). Iproteos S.L. was presented 15,000 euros for the second prize, which was sponsored by NH Hotels. Finally, the third prize, amounting to 10,000 euros and funded by the Banesto Foundation, was awarded to Terravocado SAS, a Colombian company at the “Parc I de la Universidad de Antioquia”. Iproteos, which is based at the Barcelona Science Park (Catalan acronym PCB), competed with 14 proposals promoted by universities in Argentina, Brazil, Chile, Colombia, Spain, Mexico, Peru and Portugal.
Iproteos came about from a technology transfer that was produced in Ernest Giralt’s lab at IRB Barcelona, and the University of Barcelona (UB), with the participation of the Bosch i Gimpera Foundation. Founded in 2011 by Teresa Tarragó – researcher at IRB Barcelona- and Ernest Giralt –coordinator of the Chemistry and Molecular Pharmacology Programme at the same institute and senior professor at the UB -, Iproteos seeks to develop and commercialize third generation drugs for diseases affecting the central nervous system.
RedEmprendia is an Ibero-American network of universities that aims to promote knowledge transfer, technology development, innovation and responsible entrepreneurship. It currently comprises 20 universities in 7 countries (Argentina, Brazil, Chile, Colombia, Spain, Mexico and Portugal), Universia –the largest network of Spanish- and Portuguese-speaking universities–, and the Santander Bank, through its Global Santander Universities Division.
More information: : RedEmprendia
IRB Barcelona
El Instituto de Investigación Biomédica (IRB Barcelona) trabaja para conseguir una vida libre de enfermedades. Desarrolla una investigación multidisciplinar de excelencia para curar el cáncer y otras enfermedades vinculadas al envejecimiento. Establece colaboraciones con la industria farmacéutica y los principales hospitales para hacer llegar los resultados de la investigación a la sociedad, a través de la transferencia de tecnología, y realiza diferentes iniciativas de divulgación científica para mantener un diálogo abierto con la ciudadanía. El IRB Barcelona es un centro internacional que acoge alrededor de 400 científicos de más de 30 nacionalidades. Reconocido como Centro de Excelencia Severo Ochoa desde 2011, es un centro CERCA y miembro del Barcelona Institute of Science and Technology (BIST).